☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
P-IIIb
Janssen Reports Post-Hoc Analysis of P-III GRIPHON and P-IIIb TRITON Studies of Uptravi (selexipag) for the Treatment of Pulmonary...
August 31, 2021
Janssen's Stelara Fails to Show Superiority over AbbVie's Humira in P-IIIb SEAVUE Study for Crohn's Disease- Presented at DDW 2021
May 25, 2021
Novartis Reports Results of Cosentyx (secukinumab) in P-IIIb ULTIMATE Study for Psoriatic Arthritis
November 5, 2020
Novartis Reports Results of Enerzair Breezhaler (QVM149) in P-IIIb ARGON Study to Treat Uncontrolled Asthma
June 5, 2020
Roche Reports Updated Results of Hemlibra (emicizumab) in P-III HAVEN and P-IIIb STASEY Studies for Hemophilia A
July 9, 2019
Teva Reports Results of Fremanezumab in P-IIIb FOCUS Study for Migraine in Adults
July 2, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.